Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression.

Charalampous, Charalampos; Doucette, Kimberley; Chappell, Aimee; Vesole, David H.

Afiliação

Charalampous C; Division of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
Doucette K; Division of Medicine, Georgetown University School of Medicine, Washington, DC, USA.
Chappell A; Division of Hematology and Oncology, Georgetown University School of Medicine, Washington, DC, USA.
Vesole DH; Division of Medicine, Georgetown University School of Medicine, Washington, DC, USA.

Leuk Lymphoma ; : 1-4, 2024 Aug 01.

Article em En | MEDLINE | ID: mdl-39088749